Evidence map›Paper›PMID 28077164›Full record

ArticleBreast cancer research : BCR2017

Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.

Chun-Yu Liu, Ling-Ming Tseng, Jung-Chen Su, Kung-Chi Chang, Pei-Yi Chu, Wei-Tien Tai, Chung-Wai Shiau, Kuen-Feng Chen

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research : BCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chun-Yu LiuInstitute of Biopharmaceutical Sciences, National Yang-Ming University, No. 155 Sec. 2, Li-Nong Street, Taipei, 112, Taiwan.
Ling-Ming TsengSchool of Medicine, National Yang-Ming University, No. 155, Sec. 2, Li-Nong Street, Taipei, 112, Taiwan.
Jung-Chen SuInstitute of Biopharmaceutical Sciences, National Yang-Ming University, No. 155 Sec. 2, Li-Nong Street, Taipei, 112, Taiwan.
Kung-Chi ChangInstitute of Biopharmaceutical Sciences, National Yang-Ming University, No. 155 Sec. 2, Li-Nong Street, Taipei, 112, Taiwan.
Pei-Yi ChuDepartment of Pathology, St. Martin De Porres Hospital, No. 565, Sec. 2, Daya Road, Chiayi, 600, Taiwan.
Wei-Tien TaiDepartment of Medical Research, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan.
Chung-Wai ShiauInstitute of Biopharmaceutical Sciences, National Yang-Ming University, No. 155 Sec. 2, Li-Nong Street, Taipei, 112, Taiwan. cwshiau@ym.edu.tw.
Kuen-Feng ChenDepartment of Medical Research, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan. kfchen1970@ntu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28077164
PMCPMC5225664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.